牛牛AI助理已提取核心訊息
Merck & Co. Inc. officer David Williams is set to sell 1,451 shares of common stock on 02/07/2024, with an aggregate market value of $185,108.28. The shares were originally acquired on 01/23/2023 through restricted stock vesting under a registered plan directly from the issuer. This transaction follows a period where no other securities were sold by Williams in the past three months.
Merck & Co. Inc. officer David Williams is set to sell 1,451 shares of common stock on 02/07/2024, with an aggregate market value of $185,108.28. The shares were originally acquired on 01/23/2023 through restricted stock vesting under a registered plan directly from the issuer. This transaction follows a period where no other securities were sold by Williams in the past three months.
默沙東公司公司高管戴維·威廉姆斯定於2024年7月2日出售1,451股普通股，總市值爲185,108.28美元。這些股票最初是在2023年1月23日根據註冊計劃直接從發行人處通過限制性股票歸屬收購的。這筆交易是在威廉姆斯在過去三個月中沒有出售其他證券的時期之後進行的。
默沙東公司公司高管戴維·威廉姆斯定於2024年7月2日出售1,451股普通股，總市值爲185,108.28美元。這些股票最初是在2023年1月23日根據註冊計劃直接從發行人處通過限制性股票歸屬收購的。這筆交易是在威廉姆斯在過去三個月中沒有出售其他證券的時期之後進行的。
有用
沒用